Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Next/Generation Psychedelics Recent news which mentions Next/Generation Psychedelics Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth March 27, 2024 Tickers ENVB Tags ENVB Next/Generation Psychedelics Management From Benzinga Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder March 15, 2024 Tickers NEWS Tags Next/Generation Psychedelics Cannabis Market News From Benzinga Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next? December 03, 2023 Tickers CYBN Tags Next/Generation Psychedelics Cannabis Market News From Benzinga Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice November 21, 2023 Tickers CMND Tags Markets CMND reverse stock split From Benzinga Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials November 14, 2023 Tickers ENVB Tags Next/Generation Psychedelics ENVB Market News From Benzinga Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026 November 14, 2023 Tickers ATAI CMPS Tags Benzinga Psychedelics Psychedelic/Assisted Therapies From Benzinga Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic September 18, 2023 Tickers MSSTF Tags Postpartum Depression Psychedelics Benzinga From Benzinga Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program September 06, 2023 Tickers CMND Tags CMND Markets Johns Hopkins University From Benzinga Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions August 31, 2023 Tickers CYBN DMTTF MSSTF NUGL Tags Psychedelic/Assisted Therapies Otsuka Pharmaceutical Co CYBN From Benzinga Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment August 28, 2023 Tickers ENVB Tags Benzinga Psychedelics Legal From Benzinga Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library August 16, 2023 Tickers CYBN Tags Management CYBN Psychedelic/Assisted Therapies From Benzinga Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024 August 14, 2023 Tickers ENVB Tags Markets Market News Cannabis From Benzinga Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound August 08, 2023 Tickers DRUG Tags Psychedelics Benzinga DRUG From Benzinga Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details August 01, 2023 Tickers REUN Tags News Guidance Penny Stocks From Benzinga Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application July 18, 2023 Tickers MSSTF REUN Tags Management REUN Legal From Benzinga Reunion Neuroscience On The Brink Of Going Private With Final Court Approval July 17, 2023 Tickers FTHWF MSSTF REUN Tags MSSTF News Penny Stocks From Benzinga Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research July 10, 2023 Tags Dr/ Nicholas Cozzi Psychedelics Benzinga From Benzinga This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches June 28, 2023 Tickers LOBEF Tags Benzinga Psychedelics Psychedelic/Assisted Therapies From Benzinga BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives June 28, 2023 Tickers BETRF PHRRF Tags Psychedelic/Assisted Therapies FDA PHRRF From Benzinga Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor June 28, 2023 Tickers CYBN Tags Benzinga Psychedelics Psychedelic/Assisted Therapies From Benzinga UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression June 27, 2023 Tickers MSSTF Tags MSSTF News Guidance From Benzinga Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M June 13, 2023 Tickers PMBHF Tags Market News Cannabis Markets From Benzinga Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update May 30, 2023 Tickers MYCOF Tags MYCOF News Share Offering From Benzinga This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies May 28, 2023 Tags News Benzinga Psychedelics From Benzinga Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed May 10, 2023 Tickers HUGE Tags Penny Stocks multiple sclerosis News From Benzinga Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial May 09, 2023 Tags News Delix Therapeutics Benzinga From Benzinga NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs May 05, 2023 Tags Psychedelic/Assisted Therapies Next/Generation Psychedelics WIPO From Benzinga This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection April 26, 2023 Tickers MSSTF Tags General Psychedelic/Assisted Therapies Psychedelics From Benzinga Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds April 20, 2023 Tickers DRUG SILO Tags Penny Stocks SILO Guidance From Benzinga Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference April 06, 2023 Tags Global Next/Generation Psychedelics Cannabis From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.